Feedback / Questions
indatuximab ravtansine (BT-062) - ImmunoGen, ADMA Biologics
Biotest: Press and Analyst Conference FY 2015
(Biotest)
-
Mar 26, 2016 -
Anticipated data from P1/2 trial (NCT01001442) in r/r MM in Q4 2016
Anticipated P1/2 data
•
Multiple Myeloma • Oncology
http://www.biotest.com/de/en/investor_relations/news_and_publications/publications/presentations_and_analyst_call.cfm
Mar 26, 2016
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.